Table 1 Summary of studies showing haematological complications of some post-injection COVID-19 vaccines
Patient | Vaccine or drugs | Results | Ref |
|---|---|---|---|
A 60-year-old man | Moderna mRNA vaccination | No personal or family history of haematological conditions Bone marrow biopsy confirmed very severe aplastic anemia with severely hypocellular bone marrow | [116] |
84-year-old man | Pfizer and BioNTech | One case of severe autoimmune hemolytic anemia was identified in the third week after administration of the Pfizer-BioNTech COVID-19 vaccine. However, the condition improved after corticosteroid treatment | [117] |
25-year-old man | Spikevax (mRNA-1273, Moderna Biotech, USA) | Diagnosis of thrombotic thrombocytopenic purpura after SARS-CoV-2 vaccine | [118] |
75-year-old woman | BNT162b2 | Development of autoimmune hemolytic anemia after vaccination | [119] |
69-year-old man | ChAdOx1 and BNT162b2 | TTP | [120] |
56-year-old male | Pfizer-BioNTech mRNA vaccine | AA | [121] |